Latest Shareholder Value News

Waterco Limited has announced an on-market buy-back program for up to 144,927 ordinary shares, set to run from mid-July 2025 through June 2026. The move signals a strategic approach to capital management without requiring shareholder approval.

Finbar Group has reinstated regular dividends with a fully franked 2 cent final payout for FY25, supported by a robust $36 million cash reserve and a strong development pipeline exceeding $1 billion in value.

Cromwell Property Group has provided fresh details on its Barton development, confirming a $201 million total cost and a projected yield exceeding 6.3%. This update clarifies financial expectations amid growing market interest.

Argent Minerals is fast-tracking diamond drilling and metallurgical testwork at its Kempfield Polymetallic Project to underpin a scoping study aimed at early cash flow and long-term development.

Redivium Limited has initiated a comprehensive business review and advisor appointment process aimed at exploring restructuring options to enhance long-term shareholder value and governance.

Advanced Health Intelligence has been formally delisted from NASDAQ due to shareholder equity deficiencies but is actively pursuing ASX reinstatement as a critical step toward regaining its dual-listing status.

Uvre Limited has completed its acquisition of promising New Zealand gold assets and appointed seasoned mining executives to its board, setting the stage for an accelerated exploration phase.

ClearVue Technologies initiates a thorough expenditure review and announces a key board resignation as it aims to sharpen its focus on product innovation and global expansion.

ikeGPS has successfully raised A$18 million through a fully underwritten placement, supported by strong investor demand, and is launching a A$2 million share purchase plan to fund new product development and strategic initiatives.

Indiana Resources appoints seasoned mining executive Matthew Bowles as Managing Director to spearhead expansion at its Minos Gold Project, while promoting John Fitzgerald to COO amid a strong cash position.

Pacific Edge reports steady demand for its Cxbladder cancer diagnostic tests despite losing Medicare coverage and transitioning US customers to a new test. The company is advancing clinical evidence and a $21 million capital raise to support growth and regain coverage.

Platinum Capital Limited has unveiled a proposed restructure via a scheme of arrangement, offering shareholders the option to exchange their shares for units in the Platinum International Fund Complex ETF (PIXX). The move aims to address the persistent discount to net tangible asset value (NTA) and improve liquidity.